Amlodipine Besylate
Product Images NDC 70934-067

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 70934-067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70934 067 30 Master Bottle Label Approval Rev B 01 19

Label for Amlodipine Besylate Tablets USP 10 mg, containing 30 tablets. The label shows the proprietary name, dosage strength, tablet count, and storage instructions, stating to keep out of reach of children, store in the original container, and protect from light and moisture. The label is from Denton Pharma, Inc. DBA Northwind Pharmaceuticals, and includes NDC 70934-067-30.*

FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 01

Chemical structure diagram of Amlodipine Besylate showing the arrangement of atoms and chemical bonds in the active ingredient molecule.*

FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 02

A Kaplan-Meier event rate curve comparing Amlodipine versus placebo over 24 months. The x-axis shows time in months, and the y-axis shows the event rate. Two labeled curves depict lower event rates for Amlodipine compared to placebo, with statistics including P-value, hazard ratio, and confidence interval displayed on the chart.*

FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 03

A forest plot showing hazard ratios with 95% confidence intervals comparing amlodipine to placebo across various patient subgroups including age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. Each subgroup has a corresponding marker and confidence interval line, depicting the relative favored treatment effect between amlodipine and placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.